Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 58 peer-reviewed journal articles Updated
Medical Genetics

Niemann-Pick Disease Type C: A Patient's Guide

At a Glance

Niemann-Pick Disease Type C (NPC) is a rare genetic disorder caused by mutations in the NPC1 or NPC2 genes. While it is a serious condition, new FDA-approved targeted treatments introduced in 2024 offer improved disease management and hope for patients and their families.

Receiving a diagnosis of Niemann-Pick Disease Type C (NPC) can feel overwhelming, but you are not alone. While NPC is a rare and serious genetic disorder, we have entered a new era of management. The landscape of care changed dramatically with the introduction of FDA-approved targeted treatments in 2024 [1]. These breakthroughs offer a new level of hope and a clearer path forward for families and patients navigating this journey.

This resource guide is designed to empower you with evidence-based information so you can understand your condition, advocate for the best care, and partner effectively with your medical team.

Please explore the following sections to learn more:

01

Understanding Niemann-Pick Disease Type C

Learn about Niemann-Pick Disease Type C (NPC) symptoms, causes, and the latest FDA-approved treatments like Miplyffa and Aqneursa to help manage the disease.

02

Recognizing the Many Faces of NPC Symptoms

Learn to recognize Niemann-Pick Disease Type C (NPC) symptoms across all age groups. Understand signature signs like VSGP and why it's often misdiagnosed.

03

Understanding the Biology and Diagnosis of NPC

Learn how Niemann-Pick disease type C (NPC) is diagnosed. Understand the biology, blood biomarkers like C-triol, filipin staining, and genetic test results.

04

Treatments and Managing the Disease

Learn about Niemann-Pick Type C (NPC) treatments, including Miglustat, Miplyffa, and Aqneursa. Understand how combination therapies help stabilize symptoms.

05

Building Your Specialist Care Team

Learn how to build a multidisciplinary specialist care team for Niemann-Pick Disease Type C (NPC). Discover which doctors you need and how to prep for visits.

06

Daily Management and Monitoring Expectations

Learn how to manage daily life with Niemann-Pick Type C (NPC). Understand the NPCCSS scale, supportive therapies, and ways to maintain quality of life.

Common questions in this guide

What is Niemann-Pick Disease Type C (NPC)?
NPC is a rare genetic disorder that creates a 'storage' problem within cells. It affects the body's ability to process and transport certain cellular materials properly, which can lead to progressive physical and neurological challenges.
What are the hallmark symptoms of NPC?
Symptoms vary depending on the patient's age when the disease begins. However, hallmark signs often include vertical supranuclear gaze palsy, which makes it hard to move the eyes up and down, and gelastic cataplexy, a sudden loss of muscle tone often triggered by laughing.
Are there treatments available for Niemann-Pick Disease Type C?
Yes, the landscape for managing NPC changed significantly in 2024 with the introduction of new FDA-approved targeted treatments. In addition to these medications, patients benefit greatly from physical therapy, occupational therapy, and speech-language pathology to manage daily symptoms.
What genes are responsible for causing NPC?
The condition is caused by changes (mutations) in either the NPC1 or NPC2 gene. These genetic variations create a 'broken hand-off' inside the cells, preventing them from moving vital materials like lipids to where they need to go.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my specific symptoms, which page of this guide should we focus on first?
  2. 2.Are there clinical trials or registries you recommend we join right away?
  3. 3.How often should we review the overall care plan together?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (1)
  1. 1

    Arimoclomol: First Approval.

    Keam SJ

    Drugs 2025; (85(1)):111-116 doi:10.1007/s40265-024-02129-x.

    PMID: 39715913

This guide provides educational information about Niemann-Pick Disease Type C (NPC) and its management. It is not a substitute for professional medical advice, diagnosis, or treatment from your specialist care team.

Get notified when new evidence is published on Niemann-Pick disease type C.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.